Jump to ContentJump to Main Navigation
Show Summary Details
Weitere Optionen …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2018: 156.09

Open Access
Online
ISSN
2391-5463
Alle Formate und Preise
Weitere Optionen …
Band 6, Heft 5

Hefte

Volume 10 (2015)

The relationships between depression and life activities and well-being of multiple sclerosis patients

Rytis Leonavičius
  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Republic of Lithuania
  • E-Mail
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Virginija Adomaitienė
  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Republic of Lithuania
  • E-Mail
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
/ Darius Leskauskas
  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Republic of Lithuania
  • E-Mail
  • Weitere Artikel des Autors:
  • De Gruyter OnlineGoogle Scholar
Online erschienen: 09.08.2011 | DOI: https://doi.org/10.2478/s11536-011-0059-4

Abstract

Multiple sclerosis (MS) is one of the most disabling neurodegenerative disorders. Depression is the most frequent psychiatric disorder accompanying MS. Although much attention is given to correlations between depression and MS clinical factors, analysis of correlations between depression and life activities (social, household, professional activities and family life) and the well-being of MS patients’ is insufficient. However, improvement of these functions could positively influence the outcomes of MS treatment. The aim of this study was to evaluate relationships between depression, life activities of MS patients, and their proposals how to improve the well-being. Materials and methods. The study lasted three years with 270 adult MS patients involved in it. ICD-10 criteria were used to diagnose depression. Original questionnaire was used to measure life activities and the well-being of the patients. Results. Prevalence of depression was 20.7% with no difference regarding the gender. Almost 84% of depressed respondents indicated, that MS disturbs their family life, 71.4% recommended to assign more attention to MS in general and 64.3% — to include more medications into reimbursement list. Conclusions. MS patients diagnosed with depression significantly more often than non-depressed indicate that MS disturbs their family life; recommend to assign more attention to MS in general and to include more medications into reimbursement list.

Keywords: Multiple sclerosis; Depression; Life activities; Well-being; Proposals

  • [1] Pugliatti M., Sotgiu S., Rosati G., The worldwide prevalence of multiple sclerosis, Clin. Neurol. Neurosurg., 2002, 104(3), 182–191 http://dx.doi.org/10.1016/S0303-8467(02)00036-7CrossrefGoogle Scholar

  • [2] Pugliatti M., Rosati G., Carton H., Riise T., Drulovic J., Vecsei L., et al., The epidemiology of multiple sclerosis in Europe, Eur. J. Neurol., 2006, 13(7), 700–722 http://dx.doi.org/10.1111/j.1468-1331.2006.01342.xCrossrefGoogle Scholar

  • [3] Frohman E.M., Racke M.K., Raine C.S., Multiple sclerosis — the plaque and its pathogenesis, N. Engl. J. Med., 2006, 354(9), 942–955 http://dx.doi.org/10.1056/NEJMra052130CrossrefGoogle Scholar

  • [4] Bar-Or A., Immunology of multiple sclerosis, Neurol. Clin., 2005, 23, 149–175 http://dx.doi.org/10.1016/j.ncl.2004.11.001CrossrefGoogle Scholar

  • [5] Janardhan V., Bakshi R., Quality of life in patients with multiple sclerosis: the impact of fatigue and depression, J. Neurol. Sci.., 2002, 205(1), 51–58 http://dx.doi.org/10.1016/S0022-510X(02)00312-XCrossrefGoogle Scholar

  • [6] Giannini M.J., Bergmark B., Kreshover S., Elias E., Plummer C., O’Keefe E., Understanding suicide and disability through three major disabling conditions: Intellectual disability, spinal cord injury, and multiple sclerosis, Disabil. Health J., 2010, 3(2), 74–78 http://dx.doi.org/10.1016/j.dhjo.2009.09.001CrossrefGoogle Scholar

  • [7] Fragoso Y.D., Frota E.R., Lopes J.S., Noal J.S., Giacomo M.C., Gomes S., et al., Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis, Clin. Neuropharmacol., 2010, 33(6), 312–316 http://dx.doi.org/10.1097/WNF.0b013e3181f8d513CrossrefGoogle Scholar

  • [8] Patten S.B., Beck C.A., Williams J.V., Barbui C., Metz L.M., Major depression in multiple sclerosis: a population-based perspective, Neurology, 2003, 61(11), 1524–1527 CrossrefGoogle Scholar

  • [9] Siegert R.J., Abernethy D.A., Depression in multiple sclerosis: a review, J. Neurol. Neurosurg. Psychiatry, 2005, 76(4), 469–475 http://dx.doi.org/10.1136/jnnp.2004.054635CrossrefGoogle Scholar

  • [10] Chwastiak L., Ehde D.M., Gibbons L.E., Sullivan M., Bowen J.D., Kraft G.H., Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample, Am. J. Psychiatry, 2002, 159(11), 1862–1868 http://dx.doi.org/10.1176/appi.ajp.159.11.1862CrossrefGoogle Scholar

  • [11] Wynia K., Middel B., van Dijk J.P., De Keyser J.H., Reijneveld S.A., The impact of disabilities on quality of life in people with multiple sclerosis, Mult. Scler., 2008, 14, 972–980 http://dx.doi.org/10.1177/1352458508091260CrossrefGoogle Scholar

  • [12] Putzki N., Fischer J., Gottwald K., Reifschneider G., Ries S., Siever A., et al., Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis, Eur. J. Neurol., 2009, 16, 713–720 http://dx.doi.org/10.1111/j.1468-1331.2009.02572.xCrossrefGoogle Scholar

  • [13] Hermann B.P., Vickrey B., Hays R.D., Cramer J., Devinsky O., Meador K., et al., A comparison of health-related quality of life in patients with epilepsy, diabetes, and multiple sclerosis, Epilepsy Res. 1996, 25(2), 113–118 http://dx.doi.org/10.1016/0920-1211(96)00024-1CrossrefGoogle Scholar

  • [14] Hart S., Fonareva I., Merluzzi N., Mohr D.C., Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients, Quality of Life Res., 2005, 14(3), 695–703 http://dx.doi.org/10.1007/s11136-004-1364-zCrossrefGoogle Scholar

  • [15] Sobocki P., Pugliatti M., Lauer K., Kobelt G., Estimation of the cost of MS in Europe: extrapolations from a multinational cost study, Mult. Scler., 2007, 13(8), 1054–1064 http://dx.doi.org/10.1177/1352458507077941CrossrefGoogle Scholar

  • [16] Riazi A., Hobart J., Lamping D., Fitzpatrick R., Freeman J., Jenkinson C., at al., Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles, J. Neurol. Neurosurg. Psychiatry, 2003, June, 74(6), 710–714 http://dx.doi.org/10.1136/jnnp.74.6.710CrossrefGoogle Scholar

  • [17] Kurtzke J.F., Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 1983, 33(11), 1444–1452 CrossrefGoogle Scholar

  • [18] Moran P.J., Mohr D.C., The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis, J. Behav. Med., 2005, 28(1), 35–41 http://dx.doi.org/10.1007/s10865-005-2561-0CrossrefGoogle Scholar

  • [19] Zung W.W.K., A self-rating depression scale, Arch. Gen. Psychiatry, 1965, 12, 63–70 CrossrefGoogle Scholar

  • [20] Friedman S., Even C., Samuelian J.C., Guelfi J.D., Factor structure of the Hospital Anxiety and Depression (HAD) Scale, B. J. Psychiatry, 2002, 181(8), 165–166 Google Scholar

  • [21] The ICD-10 Classification of Mental and Behavioural Disorders, Diagnostic criteria for research, World Health Organization, Geneva, 1993 Google Scholar

  • [22] Arnett P.A., Randolph J.J., Longitudinal course of depression symptoms in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 2006, 77(5), 606–610 http://dx.doi.org/10.1136/jnnp.2004.047712CrossrefGoogle Scholar

  • [23] Galeazzi G.M., Ferrari S., Giaroli G., Mackinnon A., Merelli E., Motti L., et al., Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy, Neurol. Sci., 2005, 26(4), 255–262 http://dx.doi.org/10.1007/s10072-005-0468-8CrossrefGoogle Scholar

  • [24] McGuigan C., Hutchinson M., Unrecognized symptoms of depression in a community-based population with multiple sclerosis, J. Neurol., 2006, 253(2), 219–232 http://dx.doi.org/10.1007/s00415-005-0963-0CrossrefGoogle Scholar

  • [25] Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al., The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R), JAMA, 2003, 289(23), 3095–3105 http://dx.doi.org/10.1001/jama.289.23.3095CrossrefGoogle Scholar

  • [26] Rihmer Z., Angst J., Mood disorders: epidemiology, In: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 8th ed. (1), Lippincott Williams & Wilkins, Philadelphia, 2005, 1575–1582 Google Scholar

  • [27] Piccinelli M., Wilkinson G., Gender differences in depression. Critical review, Br. J. Psychiatry, 2000, 177, 486–492 http://dx.doi.org/10.1192/bjp.177.6.486CrossrefGoogle Scholar

  • [28] Buchanan R.J., Wang S., Tai-Seale M., Ju H., Analyses of nursing home residents with multiple sclerosis and depression using the Minimum Data Set, Mult. Scler., 2003, March, 9(2), 171–188 http://dx.doi.org/10.1191/1352458503ms872oaCrossrefGoogle Scholar

  • [29] Chwastiak L.A., Ehde D.M., Psychiatric Issues in Multiple Sclerosis, Psychiatr. Clin. North. Am., 2007, 30(4), 803–817 http://dx.doi.org/10.1016/j.psc.2007.07.003CrossrefGoogle Scholar

  • [30] Sollom A.C., Kneebone I.I., Treatment of depression in people who have multiple sclerosis. Mult. Scler., 2007, Jun, 13(5), 632–635 http://dx.doi.org/10.1177/1352458507072384CrossrefGoogle Scholar

  • [31] Blazer D.G., Depression in late life: review and commentary, J. Geront.: Med. Sci., 2003, 58A(3), 249–265 http://dx.doi.org/10.1093/gerona/58.3.M249CrossrefGoogle Scholar

  • [32] Tandberg E., Larsen J.P., Aarsland D., Cummings J.L, The occurrence of depression in Parkinson’s disease. A community-based study, Arch. Neurol., 1996, 53(2), 175–179 CrossrefGoogle Scholar

  • [33] Reijnders J. S., Ehrt U., Weber W. E., Aarsland D. and Leentjens A. F., A systematic review of prevalence studies of depression in Parkinson’s disease. Mov. Disord., 2008, 23(2), 183–189 http://dx.doi.org/10.1002/mds.21803CrossrefGoogle Scholar

  • [34] Massie M.J., Prevalence of depression in patients with cancer, J. Natl. Cancer Inst. Monogr., 2004, 32, 57–71 http://dx.doi.org/10.1093/jncimonographs/lgh014CrossrefGoogle Scholar

  • [35] Ciaramella A., Poli P., Assessment of depression among cancer patients: the role of pain, cancer type and treatment, Psychooncology, 2001, 10(2), 156–165 http://dx.doi.org/10.1002/pon.505CrossrefGoogle Scholar

  • [36] Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J., The prevalence of comorbid depression in adults with diabetes. A meta-analysis, Diabetes Care, 2001, 24(6), 1069–1078 http://dx.doi.org/10.2337/diacare.24.6.1069CrossrefGoogle Scholar

  • [37] Goldney R.D., Phillips P.J., Fisher L.J., Wilson D.H., Diabetes, depression, and quality of life: a population study, Diabetes Care, 2004, 27(5), 1066–1070 http://dx.doi.org/10.2337/diacare.27.5.1066CrossrefGoogle Scholar

  • [38] Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., et al., Prevalence of depression in survivors of acute myocardial infarction, J. Gen. Int. Med., 2006, 21, 30–38 http://dx.doi.org/10.1111/j.1525-1497.2005.00269.xCrossrefGoogle Scholar

  • [39] Beal C., Stuifbergen A.K., Sands D.V., Brown A., Depression in multiple sclerosis: a longitudinal analysis, Arch. Psychiatr. Nurs., 2007, 21, 181–191 http://dx.doi.org/10.1016/j.apnu.2007.02.008CrossrefGoogle Scholar

  • [40] Minden S.L., Mood disorders in multiple sclerosis: diagnosis and treatment, J. Neurovirol., 2000, 6(2), 160–167 Google Scholar

  • [41] Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis (1): early pension and temporary unemployment—a historical prospective cohort study, Mult. Scler., 2010, Jan, 16(1), 121–126 http://dx.doi.org/10.1177/1352458509352196CrossrefGoogle Scholar

  • [42] Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis: clinical and demographic predictors — a historical prospective cohort study, Eur. J. Neurol., 2010, 17(11), 1346–1351 Google Scholar

  • [43] Julian L.J., Vella L., Vollmer T., Hadjimichael O., Mohr D.C., Employment in multiple sclerosis. Exiting and re-entering the work force, J. Neurol., 2008, 255(9), 1354–1360 http://dx.doi.org/10.1007/s00415-008-0910-yCrossrefGoogle Scholar

  • [44] Busche K.D., Fisk J.D., Murray T.J., Metz L.M., Short term predictors of unemployment in multiple sclerosis patients. Can. J. Neurol. Sci., 2003, 30(2), 137–142 Google Scholar

  • [45] Putzki M., Fischer J., Gottwald K., Reifschneider G., Ries S., Siever A. et al., Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis, Eur. J. Neurol., 2009, 16(6), 713–720 http://dx.doi.org/10.1111/j.1468-1331.2009.02572.xCrossrefGoogle Scholar

  • [46] Jongen P.J., Sindic C., Carton H., Zwanikken C., Lemmens W., Borm G., Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon beta — 1a. J. Neurol., 2010, Apr, 257(4), 584–589 http://dx.doi.org/10.1007/s00415-009-5378-xGoogle Scholar

  • [47] Einarsson U., Gottberg K., Fredrikson S., von Koch L., Holmqvist L.W., Activities of daily living and social activities in people with multiple sclerosis in Stockholm County, Clin. Rehabil., 2006, 20(6), 543–551 http://dx.doi.org/10.1191/0269215506cr953oaCrossrefGoogle Scholar

  • [48] Buhse M., Assessment of caregiver burden in families of persons with multiple sclerosis, J. Neurosci. Nurs., 2008, 40(1), 25–31 http://dx.doi.org/10.1097/01376517-200802000-00005CrossrefGoogle Scholar

  • [49] Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study, Mult. Scler., 2010, 16(7), 878–882 http://dx.doi.org/10.1177/1352458510370978Google Scholar

  • [50] MacLurg K., Reilly P., Hawkins S., Grav O., Evason E., Whittington D., A primary care-based needs assessment of people with multiple sclerosis, Br. J. Gen. Pract., 2005, 55(514), 378–383 Google Scholar

  • [51] Vazirinejad R., Lilley J., Ward C., A health profile of adults with multiple sclerosis living in the community, Mult. Scler., 2008, 14(8), 1099–1105 http://dx.doi.org/10.1177/1352458508092264CrossrefGoogle Scholar

  • [52] Koopman W.J., Benbow C.L., Vandervoort M., Top 10 needs of people with multiple sclerosis and their significant others. J. Neurosci. Nurs., 2006, 38(5), 369–373 http://dx.doi.org/10.1097/01376517-200610000-00008CrossrefGoogle Scholar

Artikelinformationen

Online erschienen: 09.08.2011

Erschienen im Druck: 01.10.2011


Quellenangabe: Open Medicine, Band 6, Heft 5, Seiten 652–661, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-011-0059-4.

Zitat exportieren

© 2011 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Zitierende Artikel

Hier finden Sie eine Übersicht über alle Crossref-gelisteten Publikationen, in denen dieser Artikel zitiert wird. Um automatisch über neue Zitierungen dieses Artikels informiert zu werden, aktivieren Sie einfach oben auf dieser Seite den „E-Mail-Alert: Neu zitiert“.

[1]
Rytis Leonavicius and Jolanta Kalnina
Neurology, Psychiatry and Brain Research, 2015, Jahrgang 21, Nummer 2, Seite 82
[2]
Rytis Leonavičius and Virginija Adomaitienė
Open Medicine, 2013, Jahrgang 8, Nummer 1

Kommentare (0)